Back to Search
TRACEY SCHEFTER, MD
MD
Radiation Oncology Physician
NPI: 1609983444Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
38685(CO)
Research & Publications (20)
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.
PMID 16029795·Int J Radiat Oncol Biol Phys·2005
3-trial
Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer.
PMID 12074470·Med Dosim·2002
6-review
Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
PMID 16053033·Oncology (Williston Park)·2005
6-review
Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
PMID 15971452·Oncology (Williston Park)·2005
8-other
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
PMID 19427740·Int J Radiat Oncol Biol Phys·2010
4-observational
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
PMID 19307945·Am J Clin Oncol·2009
3-trial
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
PMID 19255321·J Clin Oncol·2009
3-trial
Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
PMID 19255320·J Clin Oncol·2009
3-trial
Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.
PMID 18990508·Int J Radiat Oncol Biol Phys·2009
5-case
Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
PMID 18786780·Int J Radiat Oncol Biol Phys·2009
3-trial
Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
PMID 18538500·Int J Radiat Oncol Biol Phys·2009
8-other
Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
PMID 18525306·Am J Clin Oncol·2008
3-trial
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
PMID 18037584·Int J Radiat Oncol Biol Phys·2008
6-review
The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors.
PMID 17533331·J Appl Clin Med Phys·2006
8-other
Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.
PMID 16982549·Acta Oncol·2006
3-trial
Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
PMID 16317267·Am J Clin Oncol·2005
4-observational
Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization.
PMID 15609470·Oncology (Williston Park)·2004
6-review
Ovarian immature teratoma with implants and metastases.
PMID 15134355·Oncology (Williston Park)·2004
5-case
How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability?
PMID 12674231·Med Phys·2003
4-observational
Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer.
PMID 12118391·Semin Radiat Oncol·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1609983444
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile